Second drug approved for achondroplasia

American Journal of Nursing · Published 2026-06-25 · DOI 10.1097/ajn.0000000000000331b

Authors (1)

Diane S. Aschenbrenner

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Aschenbrenner, D. (2026). Second drug approved for achondroplasia. American Journal of Nursing. https://doi.org/10.1097/ajn.0000000000000331b

Related articles

• Patients, caregivers often unprepared for postsurgical challenges · American Journal of Nursing · 2026 · Same journal
• ACP position paper opposes referring to physicians as “providers.” · American Journal of Nursing · 2026 · Same journal
• On the Cover · American Journal of Nursing · 2026 · Same journal
• Empowering Patients with Heart Failure Through Health Coaching: A Quasi-Experimental Study · American Journal of Nursing · 2026 · Same journal
• Code Prep Choreography: Navigating the Urgent Interval · American Journal of Nursing · 2026 · Same journal
• Coping with Empathy Fatigue · American Journal of Nursing · 2026 · Same journal
• Staffing Mandates for Nursing Homes: the Debate Continues · American Journal of Nursing · 2026 · Same journal
• Coping With Empathy Fatigue · American Journal of Nursing · 2026 · Same journal
• A Prolonged Bouquet · American Journal of Nursing · 2026 · Same journal
• FDA approves first gene therapy for deafness. · American Journal of Nursing · 2026 · Same journal